124 related articles for article (PubMed ID: 21537842)
1. Urothelial cancer cell response to combination therapy of gemcitabine and TRAIL.
Moibi JA; Mak AL; Sun B; Moore RB
Int J Oncol; 2011 Jul; 39(1):61-71. PubMed ID: 21537842
[TBL] [Abstract][Full Text] [Related]
2. Gemcitabine-induced apoptosis in 5637 cell line: an in-vitro model for high-risk superficial bladder cancer.
Gazzaniga P; Silvestri I; Gradilone A; Scarpa S; Morrone S; Gandini O; Gianni W; Frati L; Aglianò AM
Anticancer Drugs; 2007 Feb; 18(2):179-85. PubMed ID: 17159604
[TBL] [Abstract][Full Text] [Related]
3. Gefitinib reverses TRAIL resistance in human bladder cancer cell lines via inhibition of AKT-mediated X-linked inhibitor of apoptosis protein expression.
Shrader M; Pino MS; Lashinger L; Bar-Eli M; Adam L; Dinney CP; McConkey DJ
Cancer Res; 2007 Feb; 67(4):1430-5. PubMed ID: 17308080
[TBL] [Abstract][Full Text] [Related]
4. Simultaneously targeting bcl-2 and Akt pathways sensitizes nasopharyngeal carcinoma to tumor necrosis factor-related apoptosis-inducing ligand.
Li SS; Tang QL; Wang SH; Wang S; Yang XM
Cancer Biother Radiopharm; 2012 Feb; 27(1):88-95. PubMed ID: 21936689
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor‑related apoptosis‑inducing ligand as a therapeutic option in urothelial cancer cells with acquired resistance against first‑line chemotherapy.
Vallo S; Stege H; Berg M; Michaelis M; Winkelmann R; Rothweiler F; Cinatl J
Oncol Rep; 2020 Apr; 43(4):1331-1337. PubMed ID: 32020226
[TBL] [Abstract][Full Text] [Related]
6. Response of bladder carcinoma cells to TRAIL and antisense oligonucleotide, Bcl-2 or clusterin treatments.
Sun B; Moibi JA; Mak A; Xiao Z; Roa W; Moore RB
J Urol; 2009 Mar; 181(3):1361-71. PubMed ID: 19157446
[TBL] [Abstract][Full Text] [Related]
7. Artesunate enhances TRAIL-induced apoptosis in human cervical carcinoma cells through inhibition of the NF-κB and PI3K/Akt signaling pathways.
Thanaketpaisarn O; Waiwut P; Sakurai H; Saiki I
Int J Oncol; 2011 Jul; 39(1):279-85. PubMed ID: 21537836
[TBL] [Abstract][Full Text] [Related]
8. Caspase-8 activation is necessary but not sufficient for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis in the prostatic carcinoma cell line LNCaP.
Rokhlin OW; Guseva NV; Tagiyev AF; Glover RA; Cohen MB
Prostate; 2002 Jun; 52(1):1-11. PubMed ID: 11992615
[TBL] [Abstract][Full Text] [Related]
9. Galectin-3 inhibits tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by activating Akt in human bladder carcinoma cells.
Oka N; Nakahara S; Takenaka Y; Fukumori T; Hogan V; Kanayama HO; Yanagawa T; Raz A
Cancer Res; 2005 Sep; 65(17):7546-53. PubMed ID: 16140916
[TBL] [Abstract][Full Text] [Related]
10. TRAIL-induced apoptosis in human vascular endothelium is regulated by phosphatidylinositol 3-kinase/Akt through the short form of cellular FLIP and Bcl-2.
Alladina SJ; Song JH; Davidge ST; Hao C; Easton AS
J Vasc Res; 2005; 42(4):337-47. PubMed ID: 15985761
[TBL] [Abstract][Full Text] [Related]
11. Regulation of DR-5 protein and mitochondrial transmembrane potential by gemcitabine, a possible mechanism of gemcitabine-enhanced TRAIL-induced apoptosis.
Seol JW; Chaudhari AA; Lee YJ; Kang HS; Kim IS; Kim NS; Park JH; Kim TH; Seol DW; Park SY
Oncol Rep; 2007 Sep; 18(3):523-9. PubMed ID: 17671697
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of TRAIL and gemcitabine induction of pancreatic cancer cell apoptosis.
Zhao B; Li L; Cui K; Wang CL; Wang AL; Sun ZQ; Zhang B; Zhou WY; Niu ZX; Tian H; Xue Y; Li S
Asian Pac J Cancer Prev; 2011; 12(10):2675-8. PubMed ID: 22320973
[TBL] [Abstract][Full Text] [Related]
13. Latent membrane protein 1 mediates the resistance of nasopharyngeal carcinoma cells to TRAIL-induced apoptosis by activation of the PI3K/Akt signaling pathway.
Li SS; Yang S; Wang S; Yang XM; Tang QL; Wang SH
Oncol Rep; 2011 Dec; 26(6):1573-9. PubMed ID: 21850380
[TBL] [Abstract][Full Text] [Related]
14. Bcl-2 family proteins contribute to apoptotic resistance in lung cancer multicellular spheroids.
Yang TM; Barbone D; Fennell DA; Broaddus VC
Am J Respir Cell Mol Biol; 2009 Jul; 41(1):14-23. PubMed ID: 19097992
[TBL] [Abstract][Full Text] [Related]
15. Simultaneously targeting Bcl-2 and Akt pathways reverses resistance of nasopharyngeal carcinoma to TRAIL synergistically.
Li SS; Tang QL; Wang SH; Chen YH; Liu JJ; Yang XM
Tumori; 2011; 97(6):762-70. PubMed ID: 22322844
[TBL] [Abstract][Full Text] [Related]
16. Pro-survival function of Akt/protein kinase B in prostate cancer cells. Relationship with TRAIL resistance.
Thakkar H; Chen X; Tyan F; Gim S; Robinson H; Lee C; Pandey SK; Nwokorie C; Onwudiwe N; Srivastava RK
J Biol Chem; 2001 Oct; 276(42):38361-9. PubMed ID: 11461904
[TBL] [Abstract][Full Text] [Related]
17. Implication of 4E-BP1 protein dephosphorylation and accumulation in pancreatic cancer cell death induced by combined gemcitabine and TRAIL.
Elia A; Henry-Grant R; Adiseshiah C; Marboeuf C; Buckley RJ; Clemens MJ; Mudan S; Pyronnet S
Cell Death Dis; 2017 Dec; 8(12):3204. PubMed ID: 29233971
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic adenocarcinoma cell lines show variable susceptibility to TRAIL-mediated cell death.
Ibrahim SM; Ringel J; Schmidt C; Ringel B; Müller P; Koczan D; Thiesen HJ; Löhr M
Pancreas; 2001 Jul; 23(1):72-9. PubMed ID: 11451151
[TBL] [Abstract][Full Text] [Related]
19. Restoration of TRAIL-induced apoptosis in resistant human pancreatic cancer cells by a novel FAK inhibitor, PH11.
Dao P; Smith N; Scott-Algara D; Garbay C; Herbeuval JP; Chen H
Cancer Lett; 2015 Apr; 360(1):48-59. PubMed ID: 25684663
[TBL] [Abstract][Full Text] [Related]
20. Diallyl trisulfide-induced apoptosis of bladder cancer cells is caspase-dependent and regulated by PI3K/Akt and JNK pathways.
Shin DY; Kim GY; Hwang HJ; Kim WJ; Choi YH
Environ Toxicol Pharmacol; 2014 Jan; 37(1):74-83. PubMed ID: 24309133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
